NIH-funded research Fellowship grant

Understanding the health impact of xylazine and its effects on patients

Official title: Community and big-data system approaches to identifying and understanding the health impact of xylazine

Funded at Brown University · NIH-10996326 · Data updated 2026-11-12

This study is looking into how xylazine, a sedative used for animals, affects people who use drugs, and it aims to find better ways to spot and treat issues related to its use, so we can help those who might be struggling with its effects.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionBrown University
NIH-funded
Lab location1 site (Providence, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$48,974
NIH project number1F31DA061593-01
Project IDNIH-10996326 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals under 18 years old who have been exposed to xylazine or are experiencing related health issues.

Less likely to help

Patients who have not been exposed to xylazine or are not affected by its health impacts may not benefit from this research.

What this research studies

This research investigates the health effects of xylazine, a veterinary sedative that has become a significant concern in the opioid crisis. It aims to identify patients exposed to xylazine through interviews with individuals who use drugs and to develop a natural language processing algorithm for better detection and treatment. By gathering qualitative data on overdose experiences, skin wounds, and withdrawal symptoms, the study seeks to improve clinical practices and patient outcomes related to xylazine exposure.

Why it matters

Potential benefit: If successful, this research could lead to improved identification and treatment strategies for patients affected by xylazine exposure.

How similar studies have gone: While the approach of using natural language processing for patient identification is innovative, similar qualitative research has shown promise in understanding drug-related health impacts.

Where this research is happening

  • Brown University
    Providence, United States
    Active

Researchers

  • Principal investigator: Kelly, Patrick John — Brown University
  • Study coordinator: Kelly, Patrick John

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.